State Policies on Provider Market Power

The Source is a comprehensive platform that monitors and documents various state-level activities related to healthcare prices and competition. It provides valuable resources in the form of legislation and litigation databases, which are searchable and easily accessible.

The Source is a comprehensive platform that monitors and documents various state-level activities related to healthcare prices and competition. It provides valuable resources in the form of legislation and litigation databases, which are searchable and easily accessible.

The Database of State Laws Impacting Healthcare Cost and Quality focuses on legislative measures that have an impact on the cost and quality of healthcare. This database allows stakeholders at the state level to gain insights into their legal and regulatory environment. By understanding the laws in place, these stakeholders can make informed decisions and take necessary actions to enhance access, quality, and efficiency in healthcare while also striving to reduce costs.

Additionally, The Source includes a collection of maps that offer a visual representation of notable legislation and initiatives in health policy and reform across all 50 states. These maps provide a convenient way to explore the different approaches taken by each state and the progress made in addressing healthcare challenges.

If users have specific laws or cases they are interested in, they can utilize the search functionality within the database. This feature enables targeted exploration of laws and cases pertaining to a particular state, making it easier to find relevant information.

Overall, The Source serves as a valuable tool for stakeholders involved in healthcare, providing them with the necessary information to navigate the complex landscape of healthcare legislation and policy across the United States.

Through a review of state laws, CPR found a short list of states – California, Massachusetts, Montana, New Hampshire, North Carolina, Oregon, and Rhode Island – that are particularly active in their policy efforts regarding healthcare provider consolidation and market power.

State Policies on Provider Market Power Report

The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ)

The Source on Healthcare Price & Competition

The Source tracks state activities impacting healthcare price and competition in both legislation (The Database of State Laws Impacting Healthcare Cost and Quality) and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.

Browse through the maps below to find out more about notable legislation and initiatives in health policy and reform across 50 states or search the database for specific laws and cases of a particular state.

ARTICLES & REPORT

  • by Leelah Klauber
    Now that California’s legislative session has ended, the final tallies are being compiled on what bills were signed into law and which were vetoed. Governor Newsom acted on 1,160 bills during the 2026 legislative session on topics from data centers to limiting social media for teenagers. The Source wants to highlight two influential bills with […]
  • by Bruce Allain, Managing Editor
    A pending Supreme Court petition in PhRMA v. O'Day (formerly PhRMA v. Stolfi) may test whether states can require drug manufacturers to report and publicly justify price increases. This case started with two laws the Oregon legislature passed in 2018 and 2019. District Court Sides with PhRMA The first, HB 4005, is a disclosure law. […]
  • by Bruce Allain, Managing Editor
    On September 8, 2026, Special Superior Court Judge Mark A. Davis ruled against class certification for plaintiffs in the Davis et al. v. HCA Healthcare and Mission Health System antitrust case.  The decision rested primarily on the judge's belief that plaintiffs had not proved proposed class members paid higher premiums as a result of defendants […]
  • by Anna Chau
    On September 10, 2026, Judge Quinn overruled OHCA’s demurrer, which argued that CHA lacked a beneficial interest and sufficient fact allegations to support public interest standing. Hearing Notes The Source attended a hearing on September 9, 2026, where CHA and OHCA appeared before the Superior Court of San Francisco to decide whether CHA’s second amended […]
  • by Guest Author
    By: Bernard Chao Introduction In December 2025, the US Centers for Medicare & Medicaid Services (CMS) published proposed rules for two mandatory models that link Medicare drug reimbursement to international benchmark prices. The GLOBE model (Part B) would require manufacturers of high-cost single-source drugs to rebate the difference between US prices and a benchmark derived […]
  • by Anna Chau
    On August 10th, 2026, the California Hospital Association (CHA) filed an Opposition to OHCA's Demurrer to Second Amended Petition for Writ of Mandate. In it, CHA defended its position that both its members, and itself as an organization, have standing in being harmed by the spending targets. CHA refuted California’s Office of Health Care Affordability’s […]